Selected article for: "disease prevent and immune response"
Author: Tanner, Tamara; Wahezi, Dawn M.
Title: Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19
  • Cord-id: h8hw4m9f
  • Document date: 2020_7_29
    • ID: h8hw4m9f
    Snippet: The rapid spread of SARS-CoV-2 infection globally coupled with the relatively high case-fatality rate has led to immediate need for therapeutic intervention to prevent and treat COVID-19 disease. There is accumulating evidence that morbidity and mortality in COVID-19 may be exacerbated by a dysregulated host immune response resulting in significant hyperinflammation and cytokine release. The aim of this review is to describe the basis for the immune dysregulation caused by SARS-CoV-2 infection a
    Document: The rapid spread of SARS-CoV-2 infection globally coupled with the relatively high case-fatality rate has led to immediate need for therapeutic intervention to prevent and treat COVID-19 disease. There is accumulating evidence that morbidity and mortality in COVID-19 may be exacerbated by a dysregulated host immune response resulting in significant hyperinflammation and cytokine release. The aim of this review is to describe the basis for the immune dysregulation caused by SARS-CoV-2 infection and to examine current investigations into immunomodulatory therapies aimed at targeting the excessive host immune response.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and acute severe pneumonia: 1, 2, 3, 4, 5, 6, 7
    • abdominal pain and ade antibody dependent enhancement: 1
    • abdominal pain and liver dysfunction: 1, 2, 3, 4
    • abdominal pain and liver enzyme: 1, 2, 3, 4, 5, 6, 7, 8
    • abnormal coagulation and acute severe pneumonia: 1
    • abnormal coagulation and liver dysfunction: 1
    • abnormal coagulation and liver enzyme: 1
    • acute severe pneumonia and additional evidence: 1
    • acute severe pneumonia and ade antibody dependent enhancement: 1, 2
    • acute severe pneumonia and adjunctive therapy: 1, 2, 3
    • acute severe pneumonia and liver dysfunction: 1, 2, 3
    • acute severe pneumonia and liver enzyme: 1
    • additional evidence and adjunctive therapy: 1, 2
    • additional study and ade antibody dependent enhancement: 1
    • additional study and adjunctive therapy: 1